We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$54.7B
AUM Growth
-$32.1M
(-0.06%)
Cap. Flow
-$1.71B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
1,757
New
32
Increased
448
Reduced
504
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$159M |
| 2 |
Uber
UBER
|
+$127M |
| 3 |
Broadcom
AVGO
|
+$118M |
| 4 |
Humana
HUM
|
+$89.3M |
| 5 |
KKR & Co
KKR
|
+$71.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$171M |
| 2 |
Apple
AAPL
|
+$145M |
| 3 |
Merck
MRK
|
+$107M |
| 4 |
Nike
NKE
|
+$95.7M |
| 5 |
Mastercard
MA
|
+$93.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.24% |
| 2 | Healthcare | 14.53% |
| 3 | Financials | 12.51% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Pacira BioSciences
PCRX
$1.02B
| $601K | ﹤0.01% |
21,020
| – | – |
|
1552
Iovance Biotherapeutics
IOVA
$2.23B
| $598K | ﹤0.01% |
74,592
+8,800
| +13% | +$94.3K |
|
1553
Quanex
NX
$854M
| $598K | ﹤0.01% |
21,623
| – | – |
|
1554
NCR Atleos
NATL
$3.52B
| $597K | ﹤0.01% |
22,100
| – | – |
|
1555
DXP Enterprises
DXPE
$2.62B
| $596K | ﹤0.01% |
12,994
| – | – |
|
|
SVC
1556
Service Properties Trust
SVC
$1.1B
| $587K | ﹤0.01% |
22,855
| – | – |
|
1557
AMERISAFE
AMSF
$569M
| $581K | ﹤0.01% |
13,243
| – | – |
|
1558
Integra LifeSciences
IART
$1.54B
| $580K | ﹤0.01% |
19,912
| – | – |
|
1559
TechTarget
TTGT
$246M
| $579K | ﹤0.01% |
18,564
| – | – |
|
1560
QuidelOrtho
QDEL
$1.09B
| $578K | ﹤0.01% |
17,393
+1,200
| +7% | +$49.1K |
|
1561
National Vision
EYE
$1.6B
| $577K | ﹤0.01% |
44,045
+10,850
| +33% | +$178K |
|
1562
Scholastic
SCHL
$796M
| $575K | ﹤0.01% |
16,218
| – | – |
|
|
CHCT
1563
Community Healthcare Trust
CHCT
$537M
| $574K | ﹤0.01% |
24,542
| – | – |
|
1564
Remitly
RELY
$4.74B
| $571K | ﹤0.01% |
+47,150
| New | +$731K |
|
1565
Viavi Solutions
VIAV
$9.75B
| $569K | ﹤0.01% |
82,800
| – | – |
|
1566
Novavax
NVAX
$1.23B
| $568K | ﹤0.01% |
44,900
+1,300
| +3% | +$13.1K |
|
1567
10x Genomics
TXG
$5.87B
| $567K | ﹤0.01% |
29,140
-22,453
| -44% | -$588K |
|
1568
MaxLinear
MXL
$6.49B
| $566K | ﹤0.01% |
28,112
| – | – |
|
1569
Capitol Federal Financial
CFFN
$1.08B
| $564K | ﹤0.01% |
102,718
| – | – |
|
1570
Array Technologies
ARRY
$818M
| $560K | ﹤0.01% |
54,582
+6,250
| +13% | +$79.3K |
|
1571
United Natural Foods
UNFI
$3.01B
| $559K | ﹤0.01% |
42,706
| – | – |
|
1572
Dine Brands
DIN
$432M
| $559K | ﹤0.01% |
15,448
| – | – |
|
1573
Archer Aviation
ACHR
$3.64B
| $559K | ﹤0.01% |
158,792
+51,100
| +47% | +$190K |
|
1574
Green Plains
GPRE
$1.19B
| $558K | ﹤0.01% |
35,214
+12,300
| +54% | +$237K |
|
1575
Ironwood Pharmaceuticals
IRWD
$611M
| $557K | ﹤0.01% |
85,392
| – | – |
|
Similar funds
SCP
Ensign Peak Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Ensign Peak Advisors held 1,757 positions worth $54.7B, down 0.06% from $54.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ensign Peak Advisors withdrew a net $1.71B in Q2 2024, closing 45 positions and reducing 504 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $63.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ensign Peak Advisors opened a new position in JFrog worth $30.1M.
- Ensign Peak Advisors's largest Q2 2024 buy was JFrog: 801,556 shares worth $30.1M.
- Ensign Peak Advisors added most to GE Aerospace in Q2 2024, an estimated $159M increase.
- Ensign Peak Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $171M.
- Ensign Peak Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $63.5M.
- Ensign Peak Advisors's ten largest holdings make up 33% of its $54.7B portfolio in Q2 2024.
- Ensign Peak Advisors opened 32 new positions and closed 45 in Q2 2024.
- Ensign Peak Advisors's portfolio value fell 0.06% quarter-over-quarter to $54.7B.
Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.